Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AV-001 for Neuroprotection in Hemodialysis-induced Brain Injury
NCT07234890Phase 2Recruiting
- Sponsor
- London Health Sciences Centre Research Institute
- Start
- Dec 2025
- Primary completion
- Dec 2027
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of pegevongitide in Brain Injury (BI), sponsored by London Health Sciences Centre Research Institute. Started Dec 2025; status: recruiting.
02
Drugs
pegevongitide
03
Conditions
Brain Injury (BI)
Beyond the preview
Go deeper on NCT07234890.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07234890.